MedPath

Same-Day Colectomy: is it Safe for Patients?

Not Applicable
Recruiting
Conditions
Colorectal
Colectomy
Colectomy Left/Right/Total Under Laparotomy
Registration Number
NCT07176715
Lead Sponsor
University of Arizona
Brief Summary

This is a prospective cohort study of outcomes of patients undergoing outpatient colorectal surgery at a single institution to study outpatient colectomy as a viable treatment option for a select group of patients requiring colon and rectal surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Ages 18-70
  • Undergoing robotic-assisted right colectomy, sigmoidectomy, or low anterior resection.
  • Able to perform greater than 4 metabolic equivalents (METS) without shortness of breath
  • Must have a designated adult who can care for them at home postoperatively until their in-person clinic visit
  • Access to a cell phone or computer and running water.
  • Successfully completed pre-operative and post-operative education
  • Medical criteria:
  • Well controlled hypertension with systolic blood pressure < 140 controlled by less than two medications which they are compliant with
  • Well controlled diabetes on oral agents only with blood glucose level < 180 on daily checks
  • Anti-platelet agents including aspirin, clopidogrel, prasugrel, ticagrelor or ticlopidine will be stopped 7 days preoperatively and restarted on postoperative day 1. See exclusion criteria 7 for specific exclusion criteria regarding antiplatelet agents.
Exclusion Criteria
  • Medical criteria:
  • Neurocognitive deficits not allowing for adequate preoperative education
  • Congestive heart failure with EF < 45%
  • Symptomatic aortic stenosis causing heart failure, syncope, dyspnea or angina
  • Pulmonary fibrosis or pulmonary hypertension
  • COPD or home oxygen use > 2L
  • Chronic kidney disease of any stage.
  • Lack of a caregiver at home or functionally bed-bound
  • Ultralow pelvic resection
  • Need for ostomy creation intraoperatively
  • Operative time greater than 5 hours as this likely indicates a complex case and dissection necessitating closer monitoring in the hospital
  • Conversion to open procedure intraoperatively
  • Patients receiving antiplatelet agents such as clopidogrel, prasugrel, ticagrelor or ticlopidine within one year of coronary or carotid stent implantation, TAVR or LAAO placement.
  • Patients on therapeutic anticoagulation medications such as warfarin, Eliquis, Xarelto, Enoxaparin
  • Current tobacco use
  • Patients who were unable to complete preoperative education, do not feel comfortable with care at home, or do not have an available caregiver for the first 7 postoperative days
  • Any surgical history that would preclude safe abdominal entry for robotic surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Hospital Readmission30-Days post-procedure

The primary outcome of this study is the 30-day rate of readmission to the hospital following same day colectomy

Secondary Outcome Measures
NameTimeMethod
rate of surgical site infection30-days Post Procedure
rate of deep surgical infection30-days Post Procedure
rate of anastomotic leak30-days Post-procedure
rate of bleeding requiring transfusion30-Days Post-Procedure
rate of postoperative ileus30-Days Post-Procedure
rate of reoperation30-Days Post-Procedure
reintervention30-Days Post-Procedure
rate of acute kidney injury or renal failure30-Days Post-Procedure
rate of reintubation or need for prolonged ventilation30-Days Post-Procedure
Rate of mortality30-Days Post Procedure

Trial Locations

Locations (1)

Banner University Medical Center Phoenix

🇺🇸

Phoenix, Arizona, United States

Banner University Medical Center Phoenix
🇺🇸Phoenix, Arizona, United States
Crystal Gonzalez, MSW
Contact
602-255-7553
crgonzalez4@arizona.edu
Elena Young
Contact
6022557553
elenay@arizona.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.